Marina G. Ferrari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marina G. Ferrari has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Audris Budreika
1)Department of Cancer Biology, Loyola University Chicago, Maywood, IL, USA
70 shared publications - Donald J. Vander Griend
Department of Pathology, University of Illinois at Chicago, Chicago, Illinois
70 shared publications - John T. Phoenix
Department of Cancer Biology, Loyola University Chicago, Maywood, IL, USA
70 shared publications - Raymond Joseph Kostlan
1)Department of Cancer Biology, Loyola University Chicago, Maywood, IL, USA
70 shared publications - Steven Kregel
Department of Cancer Biology, Stritch School of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL
70 shared publications - Arul M. Chinnaiyan
Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
69 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Immune-profile of T-cells in huNOG-EXL spleen.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Immune-profile of T-cells in huNOG-EXL spleen.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
22Rv1 growth in huNOG-EXL and NOG mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
22Rv1 growth in huNOG-EXL and NOG mice.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Representative histology of subcutaneous tumor, bone and liver metastasis of 22Rv1 cells in huNOG mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Representative histology of subcutaneous tumor, bone and liver metastasis of 22Rv1 cells in huNOG mice.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Immune-profile of spleen and tumor B-cell Populations and B-cell activation NK-Cell population in huNOG-EXL spleen.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Immune-profile of spleen and tumor B-cell Populations and B-cell activation NK-Cell population in huNOG-EXL spleen.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S13 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
IHC of AR and PD1 of 22Rv1 tumors in huNOG-EXL mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S13 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
IHC of AR and PD1 of 22Rv1 tumors in huNOG-EXL mice.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S12 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Multi-IF for CD3, CD8 and Granzyme B of 22Rv1 tumors in huNOG-EXL mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S12 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Multi-IF for CD3, CD8 and Granzyme B of 22Rv1 tumors in huNOG-EXL mice.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Percentage of CD3+ cells showing TNF-α expression via intracellular staining isolated from subcutaneous 22Rv1 tumors huNOG mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Percentage of CD3+ cells showing TNF-α expression via intracellular staining isolated from subcutaneous 22Rv1 tumors huNOG mice.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Metastasis by 22Rv1 to the humerus in huNOG and huNOG-EXL mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Metastasis by 22Rv1 to the humerus in huNOG and huNOG-EXL mice.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Immune-profile in huNOG-EXL 22Rv1 xenograft spleen.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Immune-profile in huNOG-EXL 22Rv1 xenograft spleen.
- Open Access
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Metastasis by 22Rv1 to the skull in huNOG and huNOG-EXL mice.
- 22 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Clinically Relevant Humanized Mouse Models of Metastatic Prostate Cancer Facilitate Therapeutic Evaluation
Metastasis by 22Rv1 to the skull in huNOG and huNOG-EXL mice.